Adicet Bio, Inc.
ACET · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,352,264 | $1,301,602 | $5,876,125 | $8,661,652 |
| - Cash | $56,495 | $159,711 | $257,656 | $277,544 |
| + Debt | $17,234 | $20,924 | $21,023 | $20,944 |
| Enterprise Value | $1,313,003 | $1,162,815 | $5,639,492 | $8,405,052 |
| Revenue | $0 | $0 | $24,990 | $9,730 |
| % Growth | – | -100% | 156.8% | – |
| Gross Profit | $0 | $0 | $24,990 | $9,730 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$110,650 | -$136,535 | -$64,701 | -$60,410 |
| % Margin | – | – | -258.9% | -620.9% |
| Net Income | -$117,122 | -$142,658 | -$69,790 | -$61,999 |
| % Margin | – | – | -279.3% | -637.2% |
| EPS Diluted | -21.28 | -52.96 | -27.2 | -32 |
| % Growth | 59.8% | -94.7% | 15% | – |
| Operating Cash Flow | -$92,378 | -$93,717 | -$44,765 | -$51,052 |
| Capital Expenditures | -$1,118 | -$4,464 | -$16,782 | -$13,046 |
| Free Cash Flow | -$93,496 | -$98,181 | -$61,547 | -$64,098 |